Double L611S/V617F JAK2 mutation in a child with erythrocytosis

被引：4
作者：
Lebecque, Benjamin [1 ]
Greze, Victoria [2 ]
Tassin, Thomas [1 ]
Mareynat, Gabrielle [1 ]
Dannus, Louis-Thomas [1 ]
Boiret-Dupre, Nathalie [1 ]
Veyrat-Masson, Richard [1 ]
Tribalat, Nathalie [1 ]
Berger, Marc Gabriel [1 ]
Bourgne, Celine [1 ]
机构：
[1] CHU Estaing, Ctr Hosp Univ Clermont Ferrand, Hematol Biol, 1 Pl L & R Aubrac, F-63003 Clermont Ferrand, France
[2] CHU Estaing, Ctr Hosp Univ Clermont Ferrand, Pediat Hematol & Oncol, Clermont Ferrand, France
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷 / 04期
关键词：
POLYCYTHEMIA; L611S; THROMBOCYTHEMIA; DIAGNOSIS; CIS;
D O I：
10.1002/pbc.28816
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Phosphorylated CIS suppresses the Epo or JAK2 V617F mutant-triggered cell proliferation through binding to EpoR
    Funakoshi-Tago, Megumi
    Moriwaki, Takuro
    Ueda, Fumihito
    Tamura, Hiroomi
    Kasahara, Tadashi
    Tago, Kenji
    CELLULAR SIGNALLING, 2017, 31 : 41 - 57
  • [32] Is the JAK2V617F mutation detectable in healthy volunteers?
    Martinaud, Christophe
    Brisou, Patrick
    Mozziconacci, Marie-Joelle
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (04) : 287 - 288
  • [33] Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients
    Ahmad, Nasir
    Qayum, Saima
    Jamee, Abid
    Ali, Asif
    Siraj, Sami
    Ali, Johar
    Yousafzai, Yasar Mehmood
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 34 (06) : 2289 - 2295
  • [34] Janus kinase (JAK) 2 V617F mutation in Asian Indians with cerebral venous thrombosis and without overt myeloproliferative disorders
    De, Tanima
    Prabhakar, Puttachandra
    Nagaraja, Dindagur
    Christopher, Rita
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 323 (1-2) : 178 - 182
  • [35] JAK2 V617F, MPL, and CALR Mutations in Essential Thrombocythaemia and Major Thrombotic Complications: A Single-Institute Retrospective Analysis
    Posfai, Eva
    Marton, Imelda
    Kiraly, Peter Attila
    Kotosz, Balazs
    Kiss-Laszlo, Zsuzsanna
    Szell, Marta
    Borbenyi, Zita
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (03) : 751 - 758
  • [36] JAK2-V617F mutation among blood donors A meta-analysis
    Alsharif, Mada H.
    Mansory, Eman M.
    Alharazi, Amjad A.
    Badawi, Maha A.
    SAUDI MEDICAL JOURNAL, 2024, 45 (12) : 1289 - 1304
  • [37] Frequency of Janus Associated Kinase 2 (V617F) Mutation in Patients of Polycythemia Vera
    Khattak, Saeed Akhtar Khan
    Ahmed, Suhaib
    Anwar, Jaleel
    Bozdar, Manzar
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2012, 22 (02): : 80 - 83
  • [38] Mutation screening for JAK2V617F:: When to order the test and how to interpret the results
    Tefferi, A
    Pardanani, A
    LEUKEMIA RESEARCH, 2006, 30 (06) : 739 - 744
  • [39] Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis
    Tognon, Raquel
    Gasparotto, Elainy P. L.
    Neves, Renata P.
    Nunes, Natalia S.
    Ferreira, Aline F.
    Palma, Patricia V. B.
    Kashima, Simone
    Covas, Dimas T.
    Santana, Mary
    Souto, Elizabeth X.
    Zanichelli, Maria Aparecida
    Simoes, Belinda P.
    de Souza, Ana Maria
    Castro, Fabiola A.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [40] Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?
    Lamy, Matthias
    Palazzo, Paola
    Agius, Pierre
    Chomel, Jean Claude
    Ciron, Jonathan
    Berthomet, Aline
    Cantagrel, Paul
    Prigent, Julia
    Ingrand, Pierre
    Puyade, Mathieu
    Neau, Jean-Philippe
    CEREBROVASCULAR DISEASES, 2017, 44 (3-4) : 97 - 104
12345